NaPDI | Compound details

Need public description.

Natural products containing this compound

Enantiomer of compound
None listed

Compound has enantiomers
None listed

Metabolite of compounds
None listed

Compound has metabolites
None listed

ID	Subject of Study	Study Name	Name	Type	Overall Effect	Enzymes	Transporters	Object	Object Metabolite	Precipitant
NPDI-SCT2WA	Cannabis (Cannabis sativa)	Influence of cannabidiol on secobarbital effects and plasma kinetics	Secobarbital Plasma Concentrations Following Sodium Secobarbital Ingestion and 500 µg/kg CBD Pretreatment	In Vivo Interaction	negative — No Effect (based on bioequivalence limits)			secobarbital		delta-9-tetrahydrocannabinol
NPDI-noOe3w	Cannabis (Cannabis sativa)	Influence of cannabidiol on secobarbital effects and plasma kinetics	Secobarbital Plasma Concentrations Following Sodium Secobarbital Ingestion and 150 µg/kg CBD Pretreatment	In Vivo Interaction	negative — No Effect (based on bioequivalence limits)			secobarbital		delta-9-tetrahydrocannabinol
NPDI-tUG7XA	Cannabis (Cannabis sativa)	Influence of cannabidiol on secobarbital effects and plasma kinetics	Plasma Concentrations of Secobarbital After Placebo Pretreatment and Oral Administration of Secobarbital	In Vivo Interaction	negative — No Effect (based on bioequivalence limits)			secobarbital		placebo

ID	Subject of Study	Name
NPDI-xYeUJQ	Cannabis (Cannabis sativa)	Influence of cannabidiol on secobarbital effects and plasma kinetics

Compound information from external resources

Resource	Identifier
Google search	KQPKPCNLIDLUMF-UHFFFAOYSA-N